Prevention of postoperative venous thromboembolism in patient with brain tumor

The surgical treatment results in 610 patients with brain tumors and thromboembolic complications were analyzed. Deep venous thrombosis was registered in 8 (1.3%) patients; 0.65% of patients died from pulmonary thromboembolism. We used complex prevention measures including low molecular weight heparin (LMWH) fraxiparine to prevent thromboembolic complications after operation. LMWH may be considered as a part of treatment standards in patients with brain tumors.